Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer

NCT00696527 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00696527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
July 31, 2008
Enrollment
1,500 (estimated)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

infiltrative breast cancer